We are monitoring the impact of COVID-19 on Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 20
Share on
Share on

Global Genetic Testing Market Analysis Report - Segmented By Type (Carrier Testing, Prenatal Testing, Diagnostic Testing, Neonatal Testing), By Application (Cancer Testing, Pharmacogenomics Testing, Prenatal Testing, Predisposition Testing), By Region - Industry Size, Share, Trends, Growth and Forecast | 2020 to 2025

Pulished: February, 2020
ID: 20
Pages: 170

Genetic Testing Market Size, Share, Trends and Growth Analysis Report (2020 to 2025)

The global genetic testing market has shown promising growth in the recent past. It is growing at a CAGR of 9.86% from 2020 to 2025.

Genetic testing is prominent in getting the information of DNA from the customers and offers many treatment procedures to the patient with the details received from their ancestry.

As per the Planet Health Organization, about 10,000 diseases are monogenic worldwide. To stop and diagnose these disorders, one has to modify or mutate one gene in every single cell of the body employing a method called genetic testing.

Market demand has shown promising growth over the following few years with an estimated average annual rate (CAGR) of between 12.5% ​​and 13.5% over the 2019-2025 forecast period. Nation government has approved a pre-implantation diagnosis for in vitro embryos. These initiatives target the detection and minimization of genetic abnormalities affecting pre-implantation embryos and therefore, the existence of regulatory agencies like the Japanese Society of Obstetrics and Gynecology (JSOG). 

Abbott Laboratories, a market leader in the genetic testing market, operates in an exceedingly kind of areas including established medicine, nutrition, diagnostics, cardiovascular and neuromodulation, headquartered within the US. In May 2019, the corporate announced WHO pre-approval of the world's first point-of-care viral load test, m-PIMA HIV-1 / 2 VL. The company's main products include chromosome enumeration probes, FISH accessories, prenatal, and prenatal.

Industry Growth Drivers

  • Increasing incidences of chronic diseases such as cancer, cardiovascular and others
  • Growing prevalence of obesity due to the adoption of a sedentary lifestyle and changes in food habits
  • Genetic testing is a prominent method in analyzing the risk of genetic diseases and also ensures quality treatment procedures, and this is propelling the genetic testing market growth
  • Growing awareness over the analysis of proteins, genes, and chromosomes is reflecting market growth towards positive.
  • An increasing number of patients with anaemia, haemophilia and cystic fibrosis across the world
  • The rise in the geriatric population
  • Growing awareness over the availability of various testing procedures among individuals
  • Increasing demand from the agriculture sector to evaluate the quality of breeding stock with the help of progeny testing is also to elevate the need for the Genetic Testing Market. It also includes checking genetic strengths and vulnerabilities of some species populations in population ecology.
  • Increasing research and development institutes to implement new techniques in diagnosing the diseases more accurately is to drive the market growth.
  • Growing crime incidences and increasing the crucial role of genetic testing in forensic investigations
  • Genetic testing creates a scope to develop personalized medicine and also improves performance in targeted therapies.

Major Challenges

  • The cost for installation of the equipment is a little high, and this attribute is restraining the demand for the genetic testing market.
  • Lack of skilled persons in analyzing the reports due to less number of training institutes
  • Genetic testing equipment in laboratories need maintenance and regular inspection to have accurate results which require lots of investments is to inhibit the demand of the market.
  • Lack of standardization in maintaining appropriate procedures in testing
  • Growing concern towards the authentication of genetic reports where people demand privacy and security.
  • Stringent rules and regulations by higher authorities in approving new products, especially to improve the services in genetic testing is also declining the demand for the global genetic testing market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on Global Genetic Testing Market segmented and sub-segmented based on type, application and region.

Genetic Testing Market - By Type:

  • Carrier Testing
  • Prenatal Testing
  • Diagnostic Testing
  • Neonatal Testing

Among all, carrier testing is leading with the highest shares of the market. Increasing support from the private and public organizations to evaluate better-diagnosing techniques is broadening the demand of this market. A growing percentage of birth rate in every country and the need for prenatal testing for the newborn is likely to expand the size of the market shares. 

Genetic Testing Market - By Application:

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

Based on application, the Cancer testing application is having prominent shares in the market. An increasing number of cancer patients due to changes in lifestyles is fueling the demand of the market extensively. Additionally, increasing expenditure on healthcare is leveraging the growth rate of the genetic testing market.

Regional Analysis

North American genetic testing market is dominating the highest shares of the global market by owing to the quick adoption of the latest technology. Launch of innovative diagnostic procedures with new technology is expanding the demand of the market in this region. Also, increasing capital income in both developed and developing countries are leveraging the growth rate of the market.

The genetic testing market in Europe is positioned second in holding the most significant shares of the market. Rise in demand for effective treatment procedures and also growing awareness over the prevention of the diseases through DNA information from ancestry is levelling up the growth rate of the market. Increasing support from the government in introducing reimbursement schemes in favour of the ordinary people is escalating the growth of the market.

Asia Pacific genetic testing market is accounted for in having the fastest growth rate from the past decade and is also to hit the highest CAGR in the coming years. The increasing elderly population is a primary factor for the market to grow in this region. Additionally, the growing prevalence of the latest equipment in research centres is bolstering the demand of the market.

The genetic testing market in Latin America is to have substantial growth opportunities with the increased revenue in most of the countries.

The Genetic testing in the Middle East and Africa are to lead the shares of the market by increasing awareness over the applications in analyzing DNA.

Some of the prominent companies leading the global genetic testing market profiled in this report are

  • Abbott Laboratories
  • Roche Molecular Diagnostics, Inc.
  • Abbott Molecular Inc.
  • Auto Genomics, Inc.
  • Celera Group
  • ELITech Group
  • BioRad Laboratories
  • PerkinElmer Inc.
  • Roche Diagnostics Corp.
  • Quest Diagnostics Inc.
  • Transgenomic Inc.
  • Applied Biosystems, Inc.

January 22, 2020, Quest Diagnostics (USA) Clinical Laboratory announces the acquisition of Finnish genetic testing company Blueprint Genetics to increase next-generation sequencing capabilities for rare diseases. Blueprint Genetics is actively engaged in the interpretation of genetic variants by expanding its presence within the US market and sequencing next-generation bioinformatics technologies. Quest is one in every of the essential laboratory testing companies within the world and is currently specializing in improving next-generation sequencing capabilities. The acquisition will allow Quest to boost genetic testing for rare genetic disorders.

In April 2018, BGI Genomic launched BGI Sentis HPV, a tool for screening HPV. This HPV test is employed to screen for cervical cancer. This initiative has helped BGI expand its genetic testing portfolio and market share.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.2 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.3 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 South Korea

                6.4 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.5 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Global Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  2. Global Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  3. Global Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  4. Global Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  5. Global Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  6. Global Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  7. Global Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  8. Global Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  9. Global Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  10. Global Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  11. Global Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  12. North America Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  13. North America Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  14. North America Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  15. North America Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  16. North America Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  17. North America Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  18. North America Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  19. North America Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  20. North America Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  21. North America Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  22. North America Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  23. United States Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  24. United States Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  25. Canada Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  26. Canada Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  27. Europe Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  28. Europe Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  29. Europe Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  30. Europe Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  31. Europe Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  32. Europe Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  33. Europe Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  34. Europe Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  35. Europe Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  36. Europe Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  37. Europe Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  38. U.K. Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  39. U.K. Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  40. Germany Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  41. Germany Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  42. France Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  43. France Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  44. Italy Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  45. Italy Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  46. Spain Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  47. Spain Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  48. Asia-Pacific Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  49. Asia-Pacific Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  50. Asia-Pacific Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  51. Asia-Pacific Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  52. Asia-Pacific Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  53. Asia-Pacific Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  54. Asia-Pacific Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  55. Asia-Pacific Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  56. Asia-Pacific Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  57. Asia-Pacific Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  58. Asia-Pacific Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  59. China Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  60. China Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  61. India Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  62. India Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  63. Japan Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  64. Japan Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  65. South Korea Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  66. South Korea Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  67. Latin America Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  68. Latin America Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  69. Latin America Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  70. Latin America Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  71. Latin America Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  72. Latin America Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  73. Latin America Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  74. Latin America Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  75. Latin America Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  76. Latin America Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  77. Latin America Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  78. Brazil Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  79. Brazil Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  80. Argentina Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  81. Argentina Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  82. Mexico Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  83. Mexico Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  84. Middle East & Africa Genetic Testing Market By Region, From 2020 to 2025 (USD Billion)
  85. Middle East & Africa Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  86. Middle East & Africa Carrier Testing Market By Region, From 2020 to 2025 (USD Billion)
  87. Middle East & Africa Diagnostic Testing Market By Region, From 2020 to 2025 (USD Billion)
  88. Middle East & Africa Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  89. Middle East & Africa Neonatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  90. Middle East & Africa Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  91. Middle East & Africa Cancer Testing Market By Region, From 2020 to 2025 (USD Billion)
  92. Middle East & Africa Prenatal Testing Market By Region, From 2020 to 2025 (USD Billion)
  93. Middle East & Africa Pharmacogenomics Testing Market By Region, From 2020 to 2025 (USD Billion)
  94. Middle East & Africa Predisposition Testing Market By Region, From 2020 to 2025 (USD Billion)
  95. Middle East Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  96. Middle East Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)
  97. Africa Genetic Testing Market By Type, From 2020 to 2025 (USD Billion)
  98. Africa Genetic Testing Market By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample